BioHealth News Archive
Emergent BioSolutions to restart COVID-19 vaccine manufacturing in Baltimore – Technical.ly Baltimore
Maryland biotech company Emergent BioSolutions said on Thursday that it was approved by the U.S. Food and Drug Administration (FDA) to resume manufacturing of…
Read More
Shuttle Pharma Awarded a New Patent for Selective Inhibitors for Cancer Treatment
ROCKVILLE, Md., July 29, 2021 /PRNewswire/ -- Shuttle Pharmaceuticals Holdings, Inc (Shuttle Pharma), a Maryland-based developer of new drugs for cancer treatment, was awarded…
Read More
Emergent BioSolutions to Resume Manufacturing Covid-19 Vaccine at Bayview Facility · BioBuzz
GAITHERSBURG, Md., July 29, 2021 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE:EBS) announced today that the U.S. Food and Drug Administration (FDA) is allowing Emergent’s Bayview manufacturing facility to resume…
Read More
The Storied 25 Year History Behind the Baltimore Biotech Manufacturing Facility Producing COVID-19 Vaccines · BioBuzz
Emergent Biosolutions’ vaccine manufacturing plant in Baltimore has been the subject of many headlines this past year for its’ role in producing several COVID-19…
Read More
Boston Properties to Acquire Maryland Biotech Campus for $117M – Commercial Observer
Boston Properties (BXP) is set to acquire the Shady Grove Bio+Tech Campus, a seven-building, 435,000-square-foot office park in Rockville, Md., for $116.5 million, from…
Read More
The Delta Variant: How Companies Should Respond
The rapidly spreading Delta variant is forcing employers to rethink their strategies for handling the pandemic. Policies they should reconsider include encouraging or requiring…
Read More
Why is the delta variant of Covid-19 more transmissible? — Quartz India
The delta variant spreads much faster than other Covid-19 strains—and scientists may now know why. People infected with the delta variant have more than…
Read More
Cerecor Announces Positive Initial Phase 1b Results for CERC-002 in Moderate to Severe Crohn’s Disease Patients
ROCKVILLE, Md. and CHESTERBROOK, Pa., July 26, 2021 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in…
Read More
Check-out JLABS quarterly portfolio update
Each quarter we bring you an update from our Johnson & Johnson Innovation – JLABS Portfolio of ompanies across our 13 sites, from San Diego…
Read More
Immunomic Therapeutics Expands Board of Directors with Appointments of Two New Members – Immunomic Therapeutics
ROCKVILLE, Md.–(BUSINESS WIRE)–Immunomic Therapeutics, Inc., (“ITI”), a privately-held clinical stage biotechnology company pioneering the study of nucleic acid immunotherapy platforms, announced today that it…
Read MoreMason’s Michael Buschmann and team at start-up AexeRNA Therapeutics Inc. pursue patents for improved COVID-19 vaccines
George Mason University bioengineering professor Michael Buschmann and a team of scientific collaborators have devised improved lipid nanoparticle technologies to deliver mRNA that could…
Read More
New Collaboration Aims to Improve Measurement of Viral Vectors Used in Cutting-Edge Gene Therapies
A large interlaboratory study of adeno-associated virus (AAV), an important tool in gene therapy, will be led by USP and NIST in collaboration with…
Read More
MaxCyte Announces Launch of Offering and Application to List on the Nasdaq Global Market
GAITHERSBURG, Md., July 26, 2021 /PRNewswire/ -- MaxCyte, Inc., (LSE: MXCT) (LSE: MXCN), a leading provider of platform technologies for cell engineering, today announced…
Read More
Jeff Boyle, President of Ellume USA, joins Rich Bendis on BioTalk
Jeff Boyle, President of Ellume USA, joins Rich Bendis on BioTalk to chat about his history, their Flagship U.S. Manufacturing Facility in Frederick, MD,…
Read More
The NIH’s Investment in Biotech Ecosystems | Bioeconomy.XYZ
The US National Institutes of Health (NIH) are the largest public supporter of basic life science in the world. With an FY2020 budget of…
Read More